Market Place
Sourcing Support
All News #Library
Biotech
Zentalis Pharma Reveals ASCO 2026 Abstract On Azenosertib Combo
21 Apr 2026 //
GLOBENEWSWIRE
Zentalis Shares Azenosertib Data in TNBC at AACR 2026
19 Apr 2026 //
FIRSTWORD PHARMA
Zentalis sets 400mg azenosertib dose for pivotal ovarian study
09 Apr 2026 //
GLOBENEWSWIRE
Zentalis Pharma To Showcase Two Posters At (AACR) Annual Meeting
17 Mar 2026 //
GLOBENEWSWIRE
Zentalis Pharma Joins Investor Conferences
18 Feb 2026 //
GLOBENEWSWIRE
Zentalis Pharma Joins Upcoming Investor Conference
03 Feb 2026 //
GLOBENEWSWIRE
Zentalis Pharma Updates Azenosertib Development For 2026
06 Jan 2026 //
GLOBENEWSWIRE
Zentalis Pharma Reveals Four Azenosertib Posters Presentations
13 Oct 2025 //
GLOBENEWSWIRE
Zentalis Pharmaceuticals to Present Posters at AACR Meeting 2025
25 Mar 2025 //
GLOBENEWSWIRE
Zentalis Pharma to Present Preclinical Azenosertib Data at ESMO 2024
09 Sep 2024 //
GLOBENEWSWIRE
Immunome Licenses Zentalis ROR1 Antibody-Drug Conjugate
08 Jan 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.